他汀类药物与缺血性脑血管病

被引：1

作者：

祝腊香 ^{[1
]}

储照虎 ^{[2
]}

机构：

[1] 皖南医学院附属芜湖市第二人民医院

[2] 皖南医学院附属弋矶山医院神经内科

来源：

国际脑血管病杂志 | 2010年 / 07期

关键词：

羟基甲基戊二酰基-CoA还原酶; 脑血管障碍; 脑缺血; 内皮细胞; 神经保护药;

D O I：

暂无

中图分类号：

R743.3 [急性脑血管疾病（中风）];

学科分类号：

摘要：

除降脂外,他汀类药物还具有广泛的多效性。文章对他汀类药物在缺血性脑血管病防治中的多效性进行了综合和归纳。

引用

页码：503 / 506

共 17 条

[11]

Effects of Statins on Endothelium and Signaling Mechanisms[J] . Matthias Endres,Ulrich Laufs.Stroke . 2004 (11 S)

[12]

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study （CARDS）: multicentre randomised placebo-controlled trial[J] . Helen M Colhoun,D John Betteridge,Paul N Durrington,Graham A Hitman,H Andrew W Neil,Shona J Livingstone,Margaret J Thomason,Michael I Mackness,Valentine Charlton-Menys,John H Fuller.The Lancet . 2004 (9435)

[13] Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease [J].

Seljeflot, I ;

Tonstad, S ;

Hjermann, I ;

Arnesen, H .

THROMBOSIS RESEARCH, 2002, 105 (04) :285-290

[14]

Reduction of Stroke Incidence After Myocardial Infarction With Pravastatin: The Cholesterol and Recurrent Events （CARE） Study[J] . Jonathan F. Plehn,Barry R. Davis,Frank M. Sacks,Jean L. Rouleau,Marc A. Pfeffer,Victoria Bernstein,T. Edward Cuddy,Lemuel A. Moye,Linda B. Piller,John Rutherford,Lara M. Simpson,Eugene Braunwald.Circulation . 1999 (2)

[15]

他汀类药物防治缺血性卒中/短暂性脑缺血发作的专家共识[更新版]. 中华内科杂志 . 2008

[16]

Comparisons of short and intermediate term effects of pitavastatin versus atorvastatin on lipid profiles fibrinolytic parameter and endothelial function. Sakabe K,Fukuda N,Fukuda Yet al. International Journal of Cardiology . 2008

[17]

Asia Pacific Cohort Studies Collaboration Cholesterol, coronary heart disease, and stroke in theAsia Pacific region. Zhang X,PatelA,HoribeH, et al. International Journal of Epidemiology . 2003

← 1 2 →